At the request of Mayo Clinic leaders, the Alumni Center team is working remotely but is checking email and telephone messages.In-person shopping for alumni merchandise on the Rochester campus is temporarily suspended. Online merchandise orders may be delayed for as long as two weeks. Thank you for your patience, understanding and ongoing support during this evolving situation.

State of Minnesota announces 5 research projects to get funding through Minnesota Partnership for Biotechnology and Medical Genomics

The state of Minnesota will fund five research projects with grants totaling $4.6 million through the Minnesota Partnership for Biotechnology and Medical Genomics. Investigators will advance early studies in medical science affecting conditions that have statewide impact. This is the 17th year for the Partnership.

Each project is a collaborative effort between a University of Minnesota investigator and a Mayo Clinic investigator.

Awarded projects focus on children’s cancer, brain tumors, pancreatic cancer and a range of neurological conditions.

Martin Fernandez-Zapico, M.D. (GI '02), Division of Medical Oncology, Mayo Clinic

Tianhong Cui, Ph.D., University of Minnesota
"Development of a High Throughput Label-Free Platform Integrating Electronic Nanosensors and Holographic Imaging for Pancreatic Cancer Early Detection"

Jann Sarkaria, M.D. (RADO '97), Department of Radiation Oncology, Mayo Clinic

Edward Hinchcliffe, Ph.D., The Hormel Institute, University of Minnesota
"Mechanistic Dissection of the K27M Histone Mutation in Pediatric Gliomagenesis"

David Daniels, M.D., Ph.D. (PRES '08, NS '13), Department of Neurologic Surgery, Mayo Clinic

Hongpo Pang, Ph.D., University of Minnesota
"Peptide-Guided Delivery System to Improve Treatment for Pediatric Diffuse Intrinsic Pontine Gliomas"

Kendall Lee, M.D., Ph.D. (NS '06), Department of Neurologic Surgery, Mayo Clinic

Jianping Wang, Ph.D., University of Minnesota
"Magnetic Nanodevice Arrays for the Treatment of Neurological Diseases"

Matthew Goetz, M.D. (HEMO '03), Division of Medical Oncology, Mayo Clinic

David Potter, M.D., Ph.D., University of Minnesota
"Overcoming Hormone Therapy Resistance in ER+HER2 - Breast Cancer by Inhibition of Epoxyeicosatrienoic Acid Driven Signaling"


Recommended reading

Posts about similar topics: